<Page>
                      THE LATIN AMERICA EQUITY FUND, INC.

- --------------------------------------------------------------------------------
            OFFER TO PURCHASE FOR CASH UP TO 1,312,576 OF ITS ISSUED
           AND OUTSTANDING SHARES AT 95% OF NET ASSET VALUE PER SHARE
- --------------------------------------------------------------------------------

    THE OFFER WILL EXPIRE AT 5:00 P.M. EASTERN TIME ON NOVEMBER 21, 2001, UNLESS
THE OFFER IS EXTENDED.

TO THE SHAREHOLDERS OF THE LATIN AMERICA EQUITY FUND, INC.:

    The Latin America Equity Fund, Inc., a non-diversified, closed-end
management investment company incorporated in Maryland (the "Fund"), is offering
to purchase up to 1,312,576 of its issued and outstanding shares of Common
Stock, par value $0.001 per share (the "Shares"). The offer is for cash at a
price equal to 95% of the net asset value ("NAV") per Share determined as of the
close of the regular trading session of the New York Stock Exchange, the
principal market in which the Shares are traded (the "NYSE"), on the date the
offer expires, and is upon the terms and subject to the conditions set forth in
this Offer to Purchase and the related form of Letter of Transmittal (which
together with any amendments or supplements thereto collectively constitute the
"Offer"). The Offer will expire at 5:00 P.M. Eastern Time on November 21, 2001,
unless extended. The Shares are traded on the NYSE under the symbol "LAQ". The
NAV as of the close of the regular trading session of the NYSE on October 19,
2001 was $13.23 per Share. During the pendency of the Offer, current NAV
quotations can be obtained from Credit Suisse Asset Management--Investor
Relations, by calling (800) 293-1232, or at www.cefsource.com, a website
providing information for closed-end funds managed by CSAM. Tendering
shareholders will not be obliged to pay brokerage fees or commissions or, except
as set forth in Instruction 7 of the Letter of Transmittal, stock transfer taxes
on the purchase of Shares by the Fund pursuant to the Offer. The Fund will pay
all charges and expenses of EquiServe Trust Company, N.A. (the "Depositary") and
Georgeson Shareholders Communication Inc. (the "Information Agent"). The Fund
has mailed materials for the Offer to record holders on or about October 24,
2001.

    THIS OFFER IS SUBJECT TO CERTAIN CONDITIONS. SEE SECTION 4.

                             IMPORTANT INFORMATION

    Shareholders who desire to tender their Shares should either: (1) properly
complete and sign the Letter of Transmittal, provide thereon the original of any
required signature guarantee(s) and mail or deliver it together with the Shares
(in proper certificated or uncertificated form) and any other documents required
by the Letter of Transmittal; or (2) request their broker, dealer, commercial
bank, trust company or other nominee to effect the transaction on their behalf.
Shareholders who desire to tender Shares registered in the name of such a firm
must contact that firm to effect a tender on their behalf. Tendering
shareholders will not be obligated to pay brokerage commissions in connection
with their tender of Shares, but they may be charged a fee by such a firm for
processing the tender(s). The Fund reserves the absolute right to reject tenders
determined not to be in appropriate form.

    If you do not wish to tender your Shares, you need not take any action.

    NEITHER THE FUND NOR ITS BOARD OF DIRECTORS NOR CREDIT SUISSE ASSET
MANAGEMENT, LLC, THE FUND'S INVESTMENT ADVISOR ("CSAM"), MAKES ANY
RECOMMENDATION TO ANY SHAREHOLDER AS TO WHETHER TO TENDER OR REFRAIN FROM
TENDERING SHARES. NO PERSON HAS BEEN AUTHORIZED TO MAKE ANY RECOMMENDATION ON
BEHALF OF THE FUND, ITS BOARD OF DIRECTORS OR CSAM AS TO WHETHER SHAREHOLDERS
SHOULD TENDER OR REFRAIN FROM TENDERING SHARES PURSUANT TO THE OFFER OR TO MAKE
ANY REPRESENTATION OR TO GIVE ANY INFORMATION IN CONNECTION WITH THE OFFER OTHER
THAN AS CONTAINED HEREIN OR IN THE LETTER OF TRANSMITTAL. IF MADE OR GIVEN, ANY
SUCH RECOMMENDATION, REPRESENTATION OR INFORMATION MUST NOT BE RELIED UPON AS
HAVING BEEN AUTHORIZED BY THE FUND, ITS BOARD OF DIRECTORS OR
<Page>
CSAM. SHAREHOLDERS ARE URGED TO EVALUATE CAREFULLY ALL INFORMATION IN THE OFFER,
CONSULT THEIR OWN INVESTMENT AND TAX ADVISERS AND MAKE THEIR OWN DECISIONS
WHETHER TO TENDER OR REFRAIN FROM TENDERING THEIR SHARES.

                     EQUISERVE TRUST COMPANY, N.A., DEPOSITARY

<Table>
                                                                         
                                          BY REGISTERED, CERTIFIED OR
                                           EXPRESS MAIL OR OVERNIGHT
                                                    COURIER:
                                         EquiServe Trust Company, N.A.
                                            Attn: Corporate Actions
                                              40 Campanelli Drive
      BY FIRST CLASS MAIL:                    Braintree, MA 02184                          BY HAND:
  EquiServe Trust Company, N.A.                                                     Securities Transfer &
     Attn: Corporate Actions                                                       Reporting Services, Inc.
         P.O. Box 43025                                                        c/o EquiServe Trust Company, N.A.
    Providence, RI 02940-3025                                                    100 William Street, Galleria
                                                                                      New York, NY 10038
</Table>

                   GEORGESON SHAREHOLDER COMMUNICATIONS INC.
                               INFORMATION AGENT
                        TELEPHONE NUMBER: (800) 498-2621
<Page>
                               TABLE OF CONTENTS

<Table>
<Caption>
                                                             PAGE
                                                             -----

                                                       
SUMMARY TERM SHEET.........................................     1

    1.   Price; Number of Shares...........................     4

    2.   Background to the Offer...........................     4

    3.   Purpose of the Offer; Plans or Proposals of the
          Fund.............................................     4

    4.   Certain Conditions of the Offer...................     5

    5.   Procedures for Tendering Shares...................     6

    6.   Withdrawal Rights.................................     9

    7.   Payment for Shares................................    10

    8.   Source and Amount of Funds........................    10

    9.   Price Range of Shares; Dividends/Distributions....    11

   10.   Selected Financial Information....................    12

   11.   Interest of Directors, Executive Officers and
          Certain Related Persons..........................    15

   12.   Certain Information about the Fund................    15

   13.   Additional Information............................    15

   14.   Certain United States Federal Income Tax
          Consequences.....................................    15

   15.   Amendments; Extension of Tender Period;
          Termination......................................    17

   16.   Miscellaneous.....................................    17
</Table>
<Page>
                               SUMMARY TERM SHEET
               (Section references are to the Offer to Purchase)

    This Summary Term Sheet highlights certain information concerning this
tender offer. To understand the offer fully and for a more complete discussion
of the terms and conditions of the offer, you should read carefully the entire
Offer to Purchase and the related form of Letter of Transmittal.

WHAT IS THE TENDER OFFER?

    - The Latin America Equity Fund, Inc. is offering to purchase up to
      1,312,576 of its shares of Common Stock for cash at a price per share
      equal to 95% of the per share net asset value as of the close of the
      regular trading session of the NYSE on November 21, 2001 (or, if the offer
      is extended, on the date to which the offer is extended) upon specified
      terms and subject to conditions as set forth in the tender offer
      documents.

WHY IS THE FUND MAKING THIS TENDER OFFER?

    - In June 2000, the Board of Directors of the Fund, as a further enhancement
      to the actions previously announced by the Fund to enhance shareholder
      value, announced a self-tender program, whereby: (i) the Fund will make a
      tender offer to acquire at least 15% of its outstanding shares during each
      calendar year of the program; and (ii) the per share purchase price will
      be at least 95% of the Fund's net asset value per share. The tender offer
      is being made in furtherance of that self-tender program.

WHEN WILL THE TENDER OFFER EXPIRE, AND MAY THE OFFER BE EXTENDED?

    - The tender offer will expire at 5:00 P.M. Eastern Time on November 21,
      2001, unless extended. The Fund may extend the period of time the offer
      will be open by issuing a press release or making some other public
      announcement by no later than the next business day after the offer
      otherwise would have expired. See Section 15.

WHAT IS THE NET ASSET VALUE PER FUND SHARE AS OF A RECENT DATE?

    - As of October 19, 2001, the net asset value per share was $13.23. See
      Section 9 of the Offer to Purchase for details. During the pendency of the
      tender offer, current net asset value quotations can be obtained from
      Credit Suisse Asset Management--Investor Relations, by calling (800)
      293-1232, or at www.cefsource.com.

WILL THE NET ASSET VALUE BE HIGHER OR LOWER ON THE DATE THAT THE PRICE TO BE
  PAID FOR TENDERED SHARES IS TO BE DETERMINED?

    - No one can accurately predict the net asset value at a future date.

HOW DO I TENDER MY SHARES?

    - If your shares are registered in your name, you should obtain the tender
      offer materials, including this Offer to Purchase and the related form of
      Letter of Transmittal, read them, and if you should decide to tender,
      complete a Letter of Transmittal and submit any other documents required
      by the Letter of Transmittal. These materials must be received by
      EquiServe Trust Company, N.A., the Depositary, in proper form before
      5:00 P.M. Eastern Time on November 21, 2001 (unless the tender offer is
      extended by the Fund in which case the new deadline

                                       1
<Page>
      will be as stated in the public announcement of the extension). If your
      shares are held by a broker, dealer, commercial bank, trust company or
      other nominee (E.G., in "street name"), you should contact that firm to
      obtain the package of information necessary to make your decision, and you
      can only tender your shares by directing that firm to complete, compile
      and deliver the necessary documents for submission to the Depositary. See
      Section 5.

MAY I WITHDRAW MY SHARES AFTER I HAVE TENDERED THEM AND, IF SO, BY WHEN?

    - Yes, you may withdraw your tendered shares at any time prior to 5:00 P.M.
      Eastern Time on November 21, 2001 (or if the offer is extended, at any
      time prior to 5:00 P.M. Eastern Time on the new expiration date).
      Withdrawn shares may be re-tendered by following the tender procedures
      before the offer expires (including any extension period). In addition, if
      shares tendered have not by then been accepted for payment, you may
      withdraw your tendered shares at any time after December 20, 2001. See
      Section 6.

HOW DO I WITHDRAW TENDERED SHARES?

    - A written notice of withdrawal of tendered shares must be timely received
      by EquiServe Trust Company, N.A., which specifies the name of the
      shareholder who tendered the shares, the number of shares being withdrawn
      (which must be all of the shares tendered) and, as regards share
      certificates which represent tendered shares that have been delivered or
      otherwise identified to EquiServe Trust Company, N.A., the name of the
      registered owner of such shares if different than the person who tendered
      the shares. See Section 6.

MAY I PLACE ANY CONDITIONS ON MY TENDER OF SHARES?

    - No.

WHAT IF MORE THAN 1,312,576 SHARES ARE TENDERED (AND NOT TIMELY WITHDRAWN)?

    - The Fund will purchase duly tendered shares from tendering shareholders
      pursuant to the terms and conditions of the tender offer on a pro rata
      basis (disregarding fractions) in accordance with the number of shares
      tendered by each shareholder (and not timely withdrawn), unless the Fund
      determines not to purchase any shares. The Fund's present intention, if
      the tender offer is oversubscribed, is not to purchase more than 1,312,576
      shares. See Section 1.

DOES THE FUND INTEND TO CONDUCT ANOTHER SELF-TENDER OFFER?

    - Pursuant to the terms of the self-tender program adopted by the Board of
      Directors of the Funs in June 2000: (i) the Fund will make a tender offer
      to acquire at least 15% of its outstanding shares during each calendar
      year of the program; and (ii) the per share purchase price will be at
      least 95% of the Fund's net asset value per share. The Board intends to
      continue its self-tender program indefinitely, subject to changes in
      economic or market conditions or other factors. See Section 3.

DOES THE FUND HAVE THE FINANCIAL RESOURCES TO MAKE PAYMENT?

    - Yes. To finance the purchase of any tendered shares, the Fund anticipates
      that funds will first be derived from any cash on hand and then from the
      proceeds from the sale of portfolio securities held by the Fund. The Fund
      is authorized to borrow money for temporary or emergency purposes, and to
      the extent the Fund does not have sufficient resources through

                                       2
<Page>
      cash on hand and the disposition of portfolio securities to purchase
      shares in the tender offer, it intends to finance a portion of the offer
      through temporary borrowing. See Section 8.

IF SHARES I TENDER ARE ACCEPTED BY THE FUND, WHEN WILL PAYMENT BE MADE?

    - It is contemplated, subject to change, that payment for tendered shares,
      if accepted, will be made on or about November 28, 2001. See Section 7.

IS MY SALE OF SHARES IN THE TENDER OFFER A TAXABLE TRANSACTION?

    - For most shareholders, yes. All U.S. shareholders (other than tax-exempt
      shareholders) who sell shares in the tender offer are expected to
      recognize gain or loss for U.S. federal income tax purposes equal to the
      difference between the cash they receive for the shares sold and their
      adjusted basis in the shares. The sale date for tax purposes will be the
      date the Fund accepts shares for purchase. See Section 14 for details,
      including the nature of the income or loss and the differing rules for
      U.S. and non-U.S. shareholders. Please consult your tax advisor as well.

IS THE FUND REQUIRED TO COMPLETE THE TENDER OFFER AND PURCHASE ALL SHARES
  TENDERED UP TO THE NUMBER OF SHARES TENDERED FOR?

    - Yes, unless certain other conditions described in Section 4 are not
      satisfied.

IS THERE ANY REASON SHARES TENDERED WOULD NOT BE ACCEPTED?

    - In addition to those circumstances described in Section 4 in which the
      Fund is not required to accept tendered shares, the Fund has reserved the
      right to reject any and all tenders determined by it not to be in
      appropriate form. Tenders will be rejected if they do not include original
      signature(s) or the original of any required signature guarantee(s).

HOW WILL TENDERED SHARES BE ACCEPTED FOR PAYMENT?

    - Properly tendered shares, up to the number tendered for, will be accepted
      for payment by a determination of the Fund's Board of Directors followed
      by notice of acceptance to EquiServe Trust Company, N.A. which is
      thereafter to make payment as directed by the Fund with funds to be
      deposited with it by the Fund. See Section 7.

WHAT ACTION NEED I TAKE IF I DECIDE NOT TO TENDER MY SHARES?

    - None.

DOES MANAGEMENT ENCOURAGE SHAREHOLDERS TO PARTICIPATE IN THE TENDER OFFER, AND
  WILL THEY PARTICIPATE IN THE TENDER OFFER?

    - No. Neither the Fund, its Board of Directors nor the Fund's investment
      advisor is making any recommendation to tender or not to tender shares in
      the tender offer. No director or officer of the Fund intends to tender
      shares. See Section 11.

HOW DO I OBTAIN INFORMATION?

    - Questions and requests for assistance should be directed to Credit Suisse
      Asset Management--Investor Relations by calling (800) 293-1232, or at
      www.cefsource.com. Requests for additional copies of the Offer to
      Purchase, the Letter of Transmittal and all other tender offer documents
      should be directed to Georgeson Shareholder Communications Inc., the
      Information Agent for the tender offer, toll free at (800) 498-2621. If
      you do not own shares directly, you should obtain this information and the
      documents from your broker, dealer, commercial bank, trust company or
      other nominee, as appropriate.

                                       3
<Page>
    1.  PRICE; NUMBER OF SHARES.  Upon the terms and subject to the conditions
of the Offer, the Fund will accept for payment and purchase for cash up to
1,312,576 of its issued and outstanding Shares that are properly tendered prior
to 5:00 P.M. Eastern Time on November 21, 2001 (and not withdrawn in accordance
with Section 6). The Fund reserves the right to amend, extend or terminate the
Offer. See Sections 4 and 15. The Fund will not be obligated to purchase Shares
pursuant to the Offer under certain circumstances. See Section 4. The later of
November 21, 2001 or the latest date to which the Offer is extended is
hereinafter called the "Expiration Date." The purchase price of the Shares will
be 95% of their NAV per Share determined as of the close of the regular trading
session of the NYSE on the Expiration Date. The Fund will not pay interest on
the purchase price under any circumstances. The NAV as of the close of the
regular trading session of the NYSE on October 19, 2001 was $13.23 per Share.
During the pendency of the Offer, current NAV quotations can be obtained from
Credit Suisse Asset Management--Investor Relations, by calling (800) 293-1232,
or at www.cefsource.com.

    The Offer is being made to all shareholders and is not conditioned upon
shareholders tendering in the aggregate any minimum number of Shares.

    If more than 1,312,576 Shares are duly tendered pursuant to the Offer (and
not withdrawn as provided in Section 6), unless the Fund determines not to
purchase any Shares, the Fund will purchase Shares from tendering shareholders,
in accordance with the terms and conditions specified in the Offer, on a pro
rata basis (disregarding fractions), in accordance with the number of Shares
duly tendered by or on behalf of each shareholder (and not so withdrawn). The
Fund does not contemplate extending the Offer and increasing the number of
Shares covered thereby by reason of more than 1,312,576 Shares having been
tendered.

    On October 19, 2001, there were 8,750,505 Shares issued and outstanding, and
there were 657 holders of record of Shares. Certain of these holders of record
were brokers, dealers, commercial banks, trust companies and other institutions
that held Shares in nominee name on behalf of multiple beneficial owners.

    2.  BACKGROUND TO THE OFFER.  The Fund's shares have generally traded at a
discount to their net asset value per share since shortly after its commencement
of operations. The Board of Directors of the Fund (the "Board") has, over the
years, discussed the significance of the existence of the discount to net asset
value at which the Fund's shares have traded on the NYSE and the impact on
shareholders of the discount. The Board has discussed and considered various
alternative strategies to address the discount and otherwise enhance shareholder
value, including instituting share repurchases, combining with other funds,
converting to an open-end format, or liquidating. The Board has, however,
consistently concluded that it was in the best interests of the Fund and its
shareholders to maintain the current closed-end format, because, in the view of
the Board and of CSAM, the closed-end format is the most appropriate investment
vehicle for participating in the Latin American equities markets. In CSAM's
view, many attractive equity investment opportunities in Latin America have been
and continue to be found in the small-capitalization and less liquid sectors of
those markets. The Board believes that the long-term performance of the Fund
supports this view.

    3.  PURPOSE OF THE OFFER; PLANS OR PROPOSALS OF THE FUND.  The tender offer
is being made in furtherance of the self-tender program announced last June by
the Fund, whereby: (i) the Fund will make a tender offer to acquire at least 15%
of its outstanding shares during each calendar year of its program; and
(ii) the per share purchase price will be at least 95% of the Fund's net asset
value per share.

    In implementing the program, the Board considered the extent to which it
should reserve flexibility with respect to the timing and the terms of specific
tenders, subject to adherence to the overall quantity and price terms described
above. The Board intends to continue its self-tender program indefinitely,
subject to changes in economic or market conditions or other factors. For
example, a sustained reduction in the market discounts at which the Fund's
shares are trading, a risk of material adverse tax consequences, or a risk of
the Fund becoming subject to de-listing may lead the Board to conclude in the
future that it is appropriate to suspend its self-tender program. In addition,
the self-tender program is likely to reduce the Fund's asset levels over time.
Absent substantial appreciation

                                       4
<Page>
in the Fund's portfolio or opportunities to raise additional funds, this could
lead to higher expense ratios, the absence of reasonable diversification or
investment opportunities or other factors that adversely affect the Fund and
possibly the continued viability of the Fund as a closed-end fund. The Board
will reevaluate the program from time to time in light of its effect on the
Fund.

    Except as set forth above, the Fund does not have any present plans or
proposals and is not engaged in any negotiations that relate to or would result
in (a) any extraordinary transaction, such as a merger, reorganization or
liquidation, involving the Fund or any of its subsidiaries; (b) other than in
connection with transactions in the ordinary course of the Fund's operations and
for purposes of funding the Offer, any purchase, sale or transfer of a material
amount of assets of the Fund or any of its subsidiaries; (c) any material change
in the Fund's present dividend rate or policy, or indebtedness or capitalization
of the Fund; (d) any change in the composition of the Board or management of the
Fund, including, but not limited to, any plans or proposals to change the number
or the term of members of the Board, to fill any existing vacancies on the Board
or to change any material term of the employment contract of any executive
officer; (e) any other material change in the Fund's corporate structure or
business, including any plans or proposals to make any changes in the Fund's
investment policy for which a vote would be required by Section 13 of the
Investment Company Act of 1940, as amended (the "1940 Act"); (f) any class of
equity securities of the Fund being delisted from a national securities exchange
or ceasing to be authorized to be quoted in an automated quotations system
operated by a national securities association; (g) any class of equity
securities of the Fund becoming eligible for termination of registration
pursuant to Section 12(g)(4) of the Exchange Act; (h) the suspension of the
Fund's obligation to file reports pursuant to Section 15(d) of the Exchange Act;
(i) the acquisition by any person of additional securities of the Fund, or the
disposition of securities of the Fund; or (j) any changes in the Fund's charter,
bylaws or other governing instruments or other actions that could impede the
acquisition of control of the Fund.

    4.  CERTAIN CONDITIONS OF THE OFFER.  Notwithstanding any other provision of
the Offer, the Fund will not purchase shares pursuant to the Offer if (a) the
Fund would not be able to liquidate portfolio securities in an orderly manner
and consistent with the Fund's investment objective and policies in order to
purchase Shares tendered pursuant to the Offer; (b) there is any (i) material
legal action or proceeding instituted or threatened which challenges, in the
Board's judgment, the Offer or otherwise materially adversely affects the Fund,
(ii) suspension of or limitation on prices for trading securities generally on
the NYSE or any foreign exchange on which portfolio securities of the Fund are
traded, (iii) declaration of a banking moratorium by Federal, state or foreign
authorities or any suspension of payment by banks in the United States, New York
State or in a foreign country which is material to the Fund, (iv) limitation
which affects the Fund or the issuers of its portfolio securities imposed by
Federal, state or foreign authorities on the extension of credit by lending
institutions or on the exchange of foreign currencies, (v) commencement of war,
armed hostilities or other international or national calamity directly or
indirectly involving the United States or any foreign country that is material
to the Fund, or (vi) other event or condition which, in the Board's judgment,
would have a material adverse effect on the Fund or its shareholders if Shares
tendered pursuant to the Offer were purchased; or (c) the Board determines that
effecting the transaction would constitute a breach of the directors' fiduciary
duty owed the Fund or its shareholders. The Board may modify these conditions in
light of experience.

    The foregoing conditions are for the Fund's sole benefit and may be asserted
by the Fund regardless of the circumstances giving rise to any such condition
(including any action or inaction of the Fund), and any such condition may be
waived by the Fund, in whole or in part, at any time and from time to time in
its reasonable judgment. The Fund's failure at any time to exercise any of the
foregoing rights shall not be deemed a waiver of any such right; the waiver of
any such right with respect to particular facts and circumstances shall not be
deemed a waiver with respect to any other facts or circumstances; and each such
right shall be deemed an ongoing right which may be asserted at any time and
from time to time. Any determination by the Fund concerning the events described
in this Section 4 shall be final and binding.

    The Fund reserves the right, at any time during the pendency of the Offer,
to amend, extend or terminate the Offer in any respect. See Section 15.

                                       5
<Page>
    5.  PROCEDURES FOR TENDERING SHARES.

        a.  PROPER TENDER OF SHARES. For Shares to be properly tendered pursuant
    to the Offer, a shareholder must cause a properly completed and duly
    executed Letter of Transmittal bearing original signature(s) and the
    original of any required signature guarantee(s), and any other documents
    required by the Letter of Transmittal, to be received by the Depositary at
    the appropriate address set forth on the cover page of the Letter of
    Transmittal and must either cause certificates for tendered Shares to be
    received by the Depositary at such address or cause such Shares to be
    delivered pursuant to the procedures for book-entry delivery set forth below
    (and confirmation of receipt of such delivery to be received by the
    Depositary), in each case before 5:00 P.M. Eastern Time on the Expiration
    Date, or (in lieu of the foregoing) such shareholder must comply with the
    guaranteed delivery procedures set forth below. Letters of Transmittal and
    certificates representing tendered Shares should not be sent or delivered to
    the Fund. Shareholders who desire to tender Shares registered in the name of
    a broker, dealer, commercial bank, trust company or other nominee must
    contact that firm to effect a tender on their behalf.

    Section 14(e) of the Exchange Act and Rule 14e-4 promulgated thereunder make
    it unlawful for any person, acting alone or in concert with others, directly
    or indirectly, to tender Shares in a partial tender offer for such person's
    own account unless at the time of tender, and at the time the Shares are
    accepted for payment, the person tendering has a net long position equal to
    or greater than the amount tendered in (a) Shares, and will deliver or cause
    to be delivered such Shares for the purpose of tender to the Fund within the
    period specified in the Offer, or (b) an equivalent security and, upon the
    acceptance of his or her tender, will acquire Shares by conversion, exchange
    or exercise of such equivalent security to the extent required by the terms
    of the Offer, and will deliver or cause to be delivered the Shares so
    acquired for the purpose of tender to the Fund prior to or on the Expiration
    Date. Section 14(e) and Rule 14e-4 provide a similar restriction applicable
    to the tender or guarantee of a tender on behalf of another person.

    The acceptance of Shares by the Fund for payment will constitute a binding
    agreement between the tendering shareholder and the Fund upon the terms and
    subject to the conditions of the Offer, including the tendering
    shareholder's representation that the shareholder has a net long position in
    the Shares being tendered within the meaning of Rule 14e-4 and that the
    tender of such Shares complies with Rule 14e-4.

        B.  SIGNATURE GUARANTEES AND METHOD OF DELIVERY. No signature guarantee
    is required if (a) the Letter of Transmittal is signed by the registered
    holder(s) (including, for purposes of this document, any participant in The
    Depository Trust Company ("DTC") book-entry transfer facility whose name
    appears on DTC's security position listing as the owner of Shares) of the
    Shares tendered thereby, unless such holder(s) has completed either the box
    entitled "Special Payment Instructions" or the box entitled "Special
    Delivery Instructions" in the Letter of Transmittal or (b) the Shares
    tendered are tendered for the account of a firm (an "Eligible Institution")
    which is a broker, dealer, commercial bank, credit union, savings
    association or other entity and which is a member in good standing of a
    stock transfer association's approved medallion program (such as STAMP, SEMP
    or MSP). In all other cases, all signatures on the Letter of Transmittal
    must be guaranteed by an Eligible Institution. See Instruction 6 of the
    Letter of Transmittal.

    If the Letter of Transmittal is signed by the registered holder(s) of the
    Shares tendered thereby, the signature(s) must correspond with the
    name(s) as written on the face of the certificate(s) for the Shares tendered
    without alteration, enlargement or any change whatsoever.

    If any of the Shares tendered thereby are owned of record by two or more
    joint owners, all such owners must sign the Letter of Transmittal.

                                       6
<Page>
    If any of the tendered Shares are registered in different names, it is
    necessary to complete, sign and submit as many separate Letters of
    Transmittal as there are different registrations.

    If the Letter of Transmittal or any certificates for Shares tendered or
    stock powers relating to Shares tendered are signed by trustees, executors,
    administrators, guardians, attorneys-in-fact, officers of corporations or
    others acting in a fiduciary or representative capacity, such persons should
    so indicate when signing, and proper evidence satisfactory to the Fund of
    their authority so to act must be submitted.

    If the Letter of Transmittal is signed by the registered holder(s) of the
    Shares transmitted therewith, no endorsements of certificates or separate
    stock powers with respect to such Shares are required unless payment is to
    be made to, or certificates for Shares not purchased are to be issued in the
    name of, a person other than the registered holder(s). Signatures on such
    certificates or stock powers must be guaranteed by an Eligible Institution.

    If the Letter of Transmittal is signed by a person other than the registered
    holder(s) of the certificate(s) listed thereon, the certificate(s) must be
    endorsed or accompanied by appropriate stock powers, in either case signed
    exactly as the name(s) of the registered holder(s) appear(s) on the
    certificate(s) for the Shares involved. Signatures on such certificates or
    stock powers must be guaranteed by an Eligible Institution. See Section 8.

        C.  BOOK-ENTRY DELIVERY. The Depositary has established an account with
    respect to the Shares at DTC for purposes of the Offer. Any financial
    institution that is a participant in the DTC system may make book-entry
    delivery of tendered Shares by causing DTC to transfer such Shares into the
    Depositary's account at DTC in accordance with DTC's procedures for such
    transfers. However, although delivery of Shares may be effected through
    book-entry transfer into the Depositary's account at DTC, a Letter of
    Transmittal properly completed and bearing original signature(s) and the
    original of any required signature guarantee(s), or an Agent's Message (as
    defined below) in connection with a book-entry transfer and any other
    documents required by the Letter of Transmittal, must in any case be
    received by the Depositary prior to 5:00 P.M. Eastern Time on the Expiration
    Date at one of its addresses set forth on the inside front cover of this
    Offer to Purchase, or the tendering shareholder must comply with the
    guaranteed delivery procedures described below.

    The term "Agent's Message" means a message from DTC transmitted to, and
    received by, the Depositary forming a part of a timely confirmation of a
    book-entry transfer of Shares (a "Book-Entry Confirmation") which states
    that (a) DTC has received an express acknowledgment from the DTC participant
    tendering the Shares that are the subject of the Book-Entry Confirmation,
    (b) the DTC participant has received and agrees to be bound by the terms of
    the Letter of Transmittal, and (c) the Fund may enforce such agreement
    against the DTC participant.

    Delivery of documents to DTC in accordance with DTC's procedures does not
    constitute delivery to the Depositary.

        D.  GUARANTEED DELIVERY. Notwithstanding the foregoing, if a shareholder
    desires to tender Shares pursuant to the Offer and the certificates for the
    Shares to be tendered are not immediately available, or time will not permit
    the Letter of Transmittal and all documents required by the Letter of
    Transmittal to reach the Depositary prior to 5:00 P.M. Eastern Time on the
    Expiration Date, or a shareholder cannot complete the procedures for
    delivery by book-entry transfer on a timely basis, then such shareholder's
    Shares may nevertheless be tendered, provided that all of the following
    conditions are satisfied:

           (i) the tender is made by or through an Eligible Institution; and

                                       7
<Page>
           (ii) a properly completed and duly executed Notice of Guaranteed
       Delivery in the form provided by the Fund is received by the Depositary
       prior to 5:00  P.M. Eastern Time on the Expiration Date; and

           (iii) the certificates for all such tendered Shares, in proper form
       for transfer, or a Book-Entry Confirmation with respect to such Shares,
       as the case may be, together with a Letter of Transmittal properly
       completed and bearing original signature(s) and the original of any
       required signature guarantee(s) (or, in the case of a book-entry
       transfer, an Agent's Message) and any documents required by the Letter of
       Transmittal, are received by the Depositary prior to 5:00 P.M. Eastern
       Time on the third NYSE trading day after the date of execution of the
       Notice of Guaranteed Delivery.

    The Notice of Guaranteed Delivery may be delivered by hand or transmitted by
    facsimile transmission or mail to the Depositary and must include a
    guarantee by an Eligible Institution and a representation that the
    shareholder owns the Shares tendered within the meaning of, and that the
    tender of the Shares effected thereby complies with, Rule 14e-4 under the
    Exchange Act, each in the form set forth in the Notice of Guaranteed
    Delivery.

   THE METHOD OF DELIVERY OF ANY DOCUMENTS, INCLUDING SHARE CERTIFICATES, THE
   LETTER OF TRANSMITTAL AND ANY OTHER REQUIRED DOCUMENTS, IS AT THE OPTION AND
   SOLE RISK OF THE TENDERING SHAREHOLDER. IF DOCUMENTS ARE SENT BY MAIL,
   REGISTERED MAIL WITH RETURN RECEIPT REQUESTED, PROPERLY INSURED, IS
   RECOMMENDED. Shareholders have the responsibility to cause their Shares
   tendered (in proper certificated or uncertificated form), the Letter of
   Transmittal properly completed and bearing original signature(s) and the
   original of any required signature guarantee(s) and any other documents
   required by the Letter of Transmittal, to be timely delivered. Timely
   delivery is a condition precedent to acceptance of Shares for purchase
   pursuant to the Offer and to payment of the purchase amount.

    Notwithstanding any other provision hereof, payment for Shares accepted for
    payment pursuant to the Offer will in all cases be made only after timely
    receipt by the Depositary of Share certificates evidencing such Shares or a
    Book-Entry Confirmation of the delivery of such Shares (if available), a
    Letter of Transmittal properly completed and bearing original
    signature(s) and the original of any required signature guarantee(s) or, in
    the case of a book-entry transfer, an Agent's Message and any other
    documents required by the Letter of Transmittal.

        E.  DETERMINATIONS OF VALIDITY. All questions as to the validity, form,
    eligibility (including time of receipt) and acceptance of tenders will be
    determined by the Fund, in its sole discretion, which determination shall be
    final and binding. The Fund reserves the absolute right to reject any or all
    tenders determined not to be in appropriate form or to refuse to accept for
    payment, purchase, or pay for, any Shares if, in the opinion of the Fund's
    counsel, accepting, purchasing or paying for such Shares would be unlawful.
    The Fund also reserves the absolute right to waive any of the conditions of
    the Offer or any defect in any tender, whether generally or with respect to
    any particular Share(s) or shareholder(s). The Fund's interpretations of the
    terms and conditions of the Offer shall be final and binding.

    NEITHER THE FUND, ITS BOARD OF DIRECTORS, CSAM, THE DEPOSITARY NOR ANY OTHER
    PERSON IS OR WILL BE OBLIGATED TO GIVE ANY NOTICE OF ANY DEFECT OR
    IRREGULARITY IN ANY TENDER, AND NONE OF THEM WILL INCUR ANY LIABILITY FOR
    FAILURE TO GIVE ANY SUCH NOTICE.

                                       8
<Page>
        F.  UNITED STATES FEDERAL INCOME TAX WITHHOLDING. To prevent the
    imposition of a U.S. federal backup withholding tax equal to 30.5% of the
    gross payments made pursuant to the Offer, prior to such payments each
    shareholder accepting the Offer who has not previously submitted to the Fund
    a correct, completed and signed Form W-9 (for U.S. Shareholders) or Form
    W-8BEN or Form W-8ECI (for Non-U.S. Shareholders), or otherwise established
    an exemption from such withholding, must submit the appropriate form to the
    Depositary. See Section 14.

        Under certain circumstances (see Section 14), the Depositary will
    withhold a tax equal to 30% of the gross payments payable to a Non-U.S.
    Shareholder unless the Depositary determines that a reduced rate of
    withholding or an exemption from withholding is applicable. (Exemption from
    backup withholding tax does not exempt a Non-U.S. Shareholder from the 30%
    withholding tax.) For this purpose, a Non-U.S. Shareholder, is, in general,
    a shareholder that is not (i) a citizen or resident of the United States,
    (ii) a corporation or a partnership (or other entity that is treated as a
    corporation or partnership for U.S. federal income tax purposes) created or
    organized in or under the laws of the United States, any State thereof or
    the District of Columbia, (iii) an estate the income of which is subject to
    United States federal income taxation regardless of the source of such
    income, or (iv) a trust if a court within the United States is able to
    exercise primary supervision over the administration of the trust and one or
    more U.S. persons have the authority to control all substantial decisions of
    the trust. The Depositary will determine a shareholder's status as a
    Non-U.S. Shareholder and the shareholder's eligibility for a reduced rate
    of, or an exemption from, withholding by reference to any outstanding
    certificates or statements concerning such eligibility, unless facts and
    circumstances indicate that such reliance is not warranted. A Non-U.S.
    Shareholder that has not previously submitted the appropriate certificates
    or statements with respect to a reduced rate of, or exemption from,
    withholding for which such shareholder may be eligible should consider doing
    so in order to avoid over-withholding. See Section 14.

    6.  WITHDRAWAL RIGHTS.  At any time prior to 5:00 P.M. Eastern Time on
November 21, 2001 (or if the offer is extended, at any time prior to 5:00 P.M.
Eastern Time on the new Expiration Date), and, if the Shares have not by then
been accepted for payment by the Fund, at any time after December 20, 2001, any
shareholder may withdraw all, but not less than all, of the Shares that the
shareholder has tendered.

    To be effective, a written notice of withdrawal of Shares tendered must be
timely received by the Depositary at the appropriate address set forth on the
inside front cover of this Offer to Purchase. Shareholders may also send a
facsimile transmission notice of withdrawal, which must be timely received by
the Depositary at (781) 575-4826 (the receipt of which may be confirmed by
calling (781) 575-4816), and the original notice of withdrawal must be delivered
to the Depositary by overnight courier or by hand the next day. Any notice of
withdrawal must specify the name(s) of the person having tendered the Shares to
be withdrawn, the number of Shares to be withdrawn (which may not be less than
all of the Shares tendered by the shareholder) and, if one or more certificates
representing such Shares have been delivered or otherwise identified to the
Depositary, the name(s) of the registered owner(s) of such Shares as set forth
in such certificate(s) if different from the name(s) of the person tendering the
Shares. If one or more certificates have been delivered to the Depositary, then,
prior to the release of such certificate(s), the certificate number(s) shown on
the particular certificate(s) evidencing such Shares must also be submitted and
the signature on the notice of withdrawal must be guaranteed by an Eligible
Institution.

    All questions as to the validity, form and eligibility (including time of
receipt) of notices of withdrawal will be determined by the Fund in its sole
discretion, which determination shall be final and binding. Shares properly
withdrawn will not thereafter be deemed to be tendered for purposes of the
Offer. Withdrawn Shares, however, may be re-tendered by following the procedures
described in Section 5 prior to 5:00 P.M. Eastern Time on the Expiration Date.
Except as otherwise provided in this Section 6, tenders of Shares made pursuant
to the Offer will be irrevocable.

                                       9
<Page>
    NEITHER THE FUND, ITS BOARD OF DIRECTORS, CSAM, THE DEPOSITARY NOR ANY OTHER
PERSON IS OR WILL BE OBLIGATED TO GIVE ANY NOTICE OF ANY DEFECT OR IRREGULARITY
IN ANY NOTICE OF WITHDRAWAL, NOR SHALL ANY OF THEM INCUR ANY LIABILITY FOR
FAILURE TO GIVE ANY SUCH NOTICE.

    7.  PAYMENT FOR SHARES.  For purposes of the Offer, the Fund will be deemed
to have accepted for payment and purchased Shares that are tendered (and not
withdrawn in accordance with Section 6 pursuant to the Offer) when, as and if it
gives oral or written notice to the Depositary of its acceptance of such Shares
for payment pursuant to the Offer. Under the Exchange Act, the Fund is obligated
to pay for or return tendered Shares promptly after the termination, expiration
or withdrawal of the Offer. Upon the terms and subject to the conditions of the
Offer, the Fund will pay for Shares properly tendered as soon as practicable
after the Expiration Date. The Fund will make payment for Shares purchased
pursuant to the Offer by depositing the aggregate purchase price therefor with
the Depositary, which will make payment to shareholders promptly as directed by
the Fund. The Fund will not pay interest on the purchase price under any
circumstances. Shares purchased in the Offer will be retired.

    In all cases, payment for Shares purchased pursuant to the Offer will be
made only after timely receipt by the Depositary of: (a) a Letter of Transmittal
(or a copy thereof) properly completed and bearing original signature(s) and any
required signature guarantee(s), (b) such Shares (in proper certificated or
uncertificated form) and (c) any other documents required by the Letter of
Transmittal. Shareholders may be charged a fee by a broker, dealer or other
institution for processing the tender requested. Certificates representing
Shares tendered but not purchased will be returned promptly following the
termination, expiration or withdrawal of the Offer, without further expense to
the tendering shareholder. The Fund will pay any transfer taxes payable on the
transfer to it of Shares purchased pursuant to the Offer. If, however, tendered
Shares are registered in the name of any person other than the person signing
the Letter of Transmittal, the amount of any such transfer taxes (whether
imposed on the registered owner or such other person) payable on account of the
transfer to such person of such Shares will be deducted from the purchase price
unless satisfactory evidence of the payment of such taxes, or exemption
therefrom, is submitted. The Fund may not be obligated to purchase Shares
pursuant to the Offer under certain conditions. See Section 4.

    Any tendering shareholder or other payee who has not previously submitted a
correct, completed and signed Form W-8BEN, Form W-8ECI or Form W-9, as
necessary, and who fails to complete fully and sign either the Form W-8BEN, Form
W-8ECI or Substitute Form W-9 in the Letter of Transmittal and provide that form
to the Depositary, may be subject to federal backup withholding tax of 30.5% of
the gross proceeds paid to such shareholder or other payee pursuant to the
Offer. See Section 14 regarding this tax as well as possible withholding at the
rate of 30% (or lower applicable treaty rate) on the gross proceeds payable to
tendering non-U.S. shareholders.

    8.  SOURCE AND AMOUNT OF FUNDS.  The total cost to the Fund of purchasing
1,312,576 of its issued and outstanding Shares pursuant to the Offer would be
$16,499,080 (based on a price per Share of $12.57, 95% of the NAV as of the
close of the regular trading session of the NYSE on October 19, 2001). On
October 19, 2001, the aggregate value of the Fund's net assets was $115,752,512.

    To pay the aggregate purchase price of Shares accepted for payment pursuant
to the Offer, the Fund anticipates that funds will first be derived from any
cash on hand and then from the proceeds from the sale of portfolio securities
held by the Fund. The selection of which portfolio securities to sell, if any,
will be made by CSAM, taking into account investment merit, relative liquidity
and applicable investment restrictions and legal requirements. The Fund is
authorized to borrow money for temporary or emergency purposes, and to the
extent the Fund does not have sufficient resources through cash on hand and the
disposition of portfolio securities to purchase Shares in the Offer, it intends
to finance a portion of the Offer through temporary borrowing. The Fund and
other investment companies or portfolios thereof advised by CSAM are parties to
a $200 million committed, unsecured line of credit (the "Facility") with a
syndicate of banks for which Deutsche Bank AG, New York Branch acts

                                       10
<Page>
as the administrative agent, The Bank of Nova Scotia acts as syndication agent,
BNP Paribas acts as documentation agent and State Street Bank and Trust Company
acts as operations agent. The Facility is intended primarily to cover temporary
or emergency needs of the Funds. Amounts drawn under the Facility bear interest
at the overnight Federal Funds rate plus 50 basis points per annum. Any amounts
drawn under the Facility will be repaid from the sale of the Fund's portfolio
securities. The Fund may specify the term of the borrowing, up to 60 days, at
the time the loan is drawn down. The amounts available to be drawn down by the
Fund under the Facility will depend upon the level of borrowings by other funds
that are parties to the Facility, and accordingly it is possible that the Fund
may not be able to borrow under the Facility the amounts desired.

    Because the Fund may sell portfolio securities to raise cash for the
purchase of Shares, during the pendency of the Offer, and possibly for a short
time thereafter, the Fund may hold a greater than normal percentage of its
assets in cash and cash equivalents. As of October 19, 2001, cash and cash
equivalents constituted approximately 3.64% of the Fund's total assets.

    Under some market circumstances, it may be necessary for the Fund to raise
cash by liquidating portfolio securities in a manner that could reduce the
market value of such securities and, thus, reduce both the NAV of the Shares and
the proceeds from the sale of such securities. Liquidating portfolio securities,
if necessary, may also lead to the premature disposition of portfolio
investments and additional transaction costs. Depending upon the timing of such
sales, any such decline in NAV may adversely affect any tendering shareholders
whose Shares are accepted for purchase by the Fund, as well as those
shareholders who do not sell Shares pursuant to the Offer. Shareholders who
retain their Shares may be subject to certain other effects of the Offer. See
Section 14.

    9.  PRICE RANGE OF SHARES; DIVIDENDS/DISTRIBUTIONS.  The following table
sets forth, for the periods indicated, the high and low NAVs per Share and the
high and low closing sale prices per Share as reported on the NYSE Composite
Tape, and the amounts of cash dividends/distributions per Share paid during such
periods.

<Table>
<Caption>
                                                                       
                                            NET ASSET VALUE*       MARKET PRICE*
                                          --------------------  --------------------
                                                                                         DIVIDENDS/
                                            HIGH        LOW       HIGH        LOW      DISTRIBUTIONS*
                                          ---------  ---------  ---------  ---------      ---------
CALENDAR YEAR (ENDING DECEMBER 31)
- ----------------------------------------
1999
  1st Quarter...........................  $  14.169  $  11.259  $   9.673  $   6.608             --
  2nd Quarter...........................     16.817     14.169     13.079      9.605             --
  3rd Quarter...........................     16.174     14.507     11.580      9.605             --
  4th Quarter...........................     19.128     14.507     13.760      9.197             --
2000
  1st Quarter...........................     21.188     18.016     15.328     13.215             --
  2nd Quarter...........................     20.087     16.556     14.441     11.513             --
  3rd Quarter...........................     20.578     18.779     14.986     13.556             --
  4th Quarter...........................     18.975     15.350     12.875     12.058      $    0.08
2001
  1st Quarter...........................     18.540     15.070     14.875     12.050             --
  2nd Quarter...........................     17.470     14.920     13.820     11.720             --
  3rd Quarter...........................     17.020     12.220     13.450      9.650      $    0.09
  4th Quarter (through October 19,
   2001)................................     13.310     12.600     11.020      9.920             --
</Table>

- ------------------------

*   For periods prior to November 10, 2000 net asset value, market price and
    dividends/distributions shown have been restated to reflect a conversion
    factor of 0.9175 for shares issued in connection with the merger of The
    Latin America Investment Fund, Inc. and The Latin America Equity, Inc.

                                       11
<Page>
    As of the close of business on October 19, 2001, the Fund's NAV was $13.23
per Share, and the high, low and closing prices per Share on the NYSE on that
date were $10.82, $10.78 and $10.80, respectively. During the pendency of the
Offer, daily NAV quotations can be obtained by contacting Credit Suisse Asset
Management--Investor Relations at (800) 293-1232, or at www.cefsource.com.

    The tendering of Shares, unless and until shares tendered are accepted for
payment and purchase, will not affect the record ownership of any such tendered
Shares for purposes of entitlement to any dividends payable by the Fund. The
Fund expects to pay a dividend distribution for the fiscal year ending
December 31, 2001.

    10.  SELECTED FINANCIAL INFORMATION.  The following table is intended to
help you understand the financial performance of the Fund. This information is
derived from financial and accounting records of the Fund.

    This information, except for the information for the six months ended
June 30, 2001, as noted in the table, has been audited by PricewaterhouseCoopers
LLP, the Fund's independent auditors, whose reports, along with the Fund's
financial statements, are incorporated herein by reference and included in the
Fund's Annual Report to Shareholders. The Annual Reports may be obtained without
charge, by writing to Georgeson Shareholder Communications Inc., 17 State
Street, New York, New York 10004, or by calling (800) 403-7916.

                                       12
<Page>
- --------------------------------------------------------------------------------
THE LATIN AMERICA EQUITY FUND, INC.

FINANCIAL HIGHLIGHTS
- --------------------------------------------------------------------------------

The following table includes per share operating performance data for a share of
common stock outstanding, total investment return, ratios to average net assets
and other supplemental data for each period indicated. This information has been
derived from information provided in the financial statements and market price
data for the Fund's shares.
- --------------------------------------------------------------------------------

<Table>
<Caption>
                                                  For the Six
                                                  Months Ended                   FOR THE YEARS ENDED DECEMBER 31,
                                                 June 30, 2001    ---------------------------------------------------------------
                                                  (Unaudited)       2000       1999       1998       1997       1996       1995
                                                 --------------   --------   --------   --------   --------   --------   --------
                                                                                                    
 PER SHARE OPERATING PERFORMANCE
Net asset value, beginning of period...........       $16.60        $18.57     $10.96    $18.77      $18.41     $16.27     $19.53
                                                    --------      --------   --------   -------    --------   --------   --------
Net investment income..........................         0.33         (0.11)+     0.07+     0.16        0.16       0.21       0.07
Net realized and unrealized gain/(loss) on
  investments and foreign currency related
  transactions.................................        (0.06)        (2.44)      7.07     (7.85)++     2.01       2.00      (3.07)
                                                    --------      --------   --------   -------    --------   --------   --------
Net increase/(decrease) in net assets resulting
  from operations..............................         0.27         (2.55)      7.14     (7.69)       2.17       2.21      (3.00)
                                                    --------      --------   --------   -------    --------   --------   --------
Dividends and distributions to shareholders:
  Net investment income........................           --         (0.08)        --     (0.12)      (0.17)     (0.07)        --
  Net realized gain on investments and foreign
    currency related transactions..............           --            --         --        --       (1.64)        --      (0.26)
  In excess of net realized gains..............           --            --         --        --          --         --         --
                                                    --------      --------   --------   -------    --------   --------   --------
Total dividends and distributions to
  shareholders.................................           --         (0.08)        --     (0.12)      (1.81)     (0.07)     (0.26)
                                                    --------      --------   --------   -------    --------   --------   --------
Anti-dilutive impact due to capital shares
  repurchased..................................           --          0.66       0.47        --          --         --         --
Effect of reduction of accrued offering
  costs........................................           --            --         --        --          --         --         --
Dilutive impact due to capital share rights
  offering.....................................           --            --         --        --          --         --         --
                                                    --------      --------   --------   -------    --------   --------   --------
Net asset value, end of period.................       $16.87        $16.60     $18.57    $10.96      $18.77     $18.41     $16.27
                                                    ========      ========   ========   =======    ========   ========   ========
Market value, end of period....................     $  13.30      $ 12.875   $ 13.760   $ 7.834    $ 14.918   $ 15.259   $ 14.033
                                                    ========      ========   ========   =======    ========   ========   ========
Total investment return (a) ...................         3.30%        (5.87)%    75.65%   (46.63)%     10.29%      9.18%    (25.65)%
                                                    ========      ========   ========   =======    ========   ========   ========
 RATIOS/SUPPLEMENTAL DATA
Net assets, end of period (000 omitted)........     $147,644      $145,281   $123,262   $86,676    $148,130   $145,230   $128,377
Ratio of expenses to average net assets (b) ...         1.40%(c)      2.13%      2.14%     2.41%       1.89%      1.69%      2.04%
Ratio of expenses to average net assets,
  excluding fee waivers........................           --          2.19%      2.22%     2.60%       2.02%      1.80%      2.15%
Ratio of expenses to average net assets,
  excluding taxes..............................         1.30%(c)      2.03%      2.05%     1.77%       1.65%        --       1.81%
Ratio of net investment income to average net
  assets.......................................         3.91%(c)     (0.55)%     0.46%     1.12%       0.77%      1.16%      0.42%
Portfolio turnover rate........................        53.41%       125.83%    161.71%   142.35%     111.83%     43.22%     27.05%
- ---------------------------------------------------------------------------------------------------------------------------------
</Table>

<Table>
                      
Per share amounts prior to November 10, 2000 have been restated to reflect a
conversion factor of 0.9175 for shares issued in connection with the merger of The
Latin America Investment Fund, Inc. and The Latin America Equity Fund, Inc.
          *              Commencement of investment operations.
         **              Initial public offering price of $16.35 per share less
                         underwriting discount of $1.14 per share and offering
                         expenses of $0.11 per share.
          +              Based on average shares outstanding.
         ++              Includes a $0.01 per share decrease to the Fund's net asset
                         value per share resulting from the dilutive impact of shares
                         issued pursuant to the Fund's automatic dividend
                         reinvestment program.
         (a)             Total investment return at market value is based on the
                         changes in market price of a share during the period and
                         assumes reinvestment of dividends and distributions, if any,
                         at actual prices pursuant to the Fund's dividend
                         reinvestment program. Total investment return does not
                         reflect brokerage commissions or initial underwriting
                         discounts and has not been annualized.
         (b)             Ratios reflect actual expenses incurred by the fund. Amounts
                         are net of fee waivers and inclusive of taxes.
         (c)             Annualized.
</Table>

- --------------------------------------------------------------------------------

                                       13
<Page>
- --------------------------------------------------------------------------------

- --------------------------------------------------------------------------------

<Table>
<Caption>
                                                                                                          For the Period
                                                                                                        October 30, 1991*
                                                                 Fiscal Year Ended December 31,              through
                                                              ------------------------------------         December 31,
                                                                1994          1993          1992               1991
                                                              --------      --------      --------      ------------------
                                                                                            
 PER SHARE OPERATING PERFORMANCE
Net asset value, beginning of period....................      $  24.52      $  15.66      $ 16.83            $  15.10**
                                                              --------      --------      -------            --------
Net investment income...................................          0.01+         0.12+        0.23                0.07
Net realized and unrealized gain/(loss) on investments
  and foreign currency related transactions.............          1.05          9.54         0.47                1.74
                                                              --------      --------      -------            --------
Net increase/(decrease) in net assets resulting from
  operations............................................          1.06          9.66         0.70                1.81
                                                              --------      --------      -------            --------
Dividends and distributions to shareholders:
  Net investment income.................................         (0.18)           --        (0.23)              (0.07)
  Net realized gain on investments and foreign currency
    related transactions................................         (3.38)        (0.82)       (1.44)              (0.01)
  In excess of net realized gains.......................            --            --        (0.20)                 --
                                                              --------      --------      -------            --------
Total dividends and distributions to shareholders.......         (3.56)        (0.82)       (1.87)              (0.08)
                                                              --------      --------      -------            --------
Anti-dilutive impact due to capital shares
  repurchased...........................................            --            --           --                  --
Effect of reduction of accrued offering costs...........            --          0.02           --                  --
Dilutive impact due to capital share rights offering....         (2.49)           --           --                  --
                                                              --------      --------      -------            --------
Net asset value, end of period..........................        $19.53        $24.52       $15.66              $16.83
                                                              ========      ========      =======            ========
Market value, end of period.............................      $ 19.210      $ 27.929      $15.259            $ 14.714
                                                              ========      ========      =======            ========
Total investment return (a) ............................        (17.78)%       89.35%       16.49%              (2.73)%
                                                              ========      ========      =======            ========
 RATIOS/SUPPLEMENTAL DATA
Net assets, end of period (000 omitted).................      $153,128      $135,573      $86,359             $92,751
Ratio of expenses to average net assets (b) ............          1.94%         2.00%        2.20%               2.35%(c)
Ratio of expenses to average net assets, excluding fee
  waivers...............................................            --            --           --                  --
Ratio of expenses to average net assets, excluding
  taxes.................................................          1.70%           --           --                  --
Ratio of net investment income to average net assets....          0.04%         0.63%        1.27%               2.46%(c)
Portfolio turnover rate.................................         68.46%        49.48%       68.70%              11.58%

- --------------------------------------------------------------------------------------------------------------------------
</Table>

                                       14
<Page>
    11.  INTEREST OF DIRECTORS, EXECUTIVE OFFICERS AND CERTAIN RELATED
PERSONS.  Information, as of particular dates, concerning the Fund's directors
and executive officers, their remuneration, any material interest of such
persons in transactions with the Fund and other matters is required to be
disclosed in proxy statements distributed to the Fund's shareholders in proxy
statements distributed to the Fund's shareholders and filed with the Securities
and Exchange Commission (the "SEC"). Neither the Fund nor, to the best of the
Fund's knowledge, any of the Fund's directors or executive officers, has
effected any transaction in Shares during the 60 days before the date hereof.

    Except as set forth in this Offer, neither the Fund, nor, to the best of the
Fund's knowledge, any of the Fund's directors or executive officers, is a party
to any contract, arrangement, understanding or relationship with any other
person relating, directly or indirectly to the Offer with respect to any
securities of the Fund, including, but not limited to, any contract,
arrangement, understanding or relationship concerning the transfer or the voting
of any such securities, joint ventures, loan or option arrangements, puts or
calls, guaranties of loans, guaranties against loss or the giving or withholding
of proxies, consents or authorizations. Based upon information provided or
available to the Fund, no director or officer of the Fund intends to tender
Shares pursuant to the Offer. The Offer does not, however, restrict the purchase
of shares pursuant to the Offer from any such person.

    12.  CERTAIN INFORMATION ABOUT THE FUND.  The Fund is a Maryland corporation
with its principal executive offices located at 466 Lexington Avenue, 16th
Floor, New York, New York 10017 (telephone number (212) 875-3500). The Fund is a
closed-end, non-diversified, management investment company organized as a
Maryland corporation. As a closed-end investment company the Fund differs from
an open-end investment company (I.E. , a mutual fund) in that it does not redeem
its Shares at the election of a shareholder and does not continuously offer its
Shares for sale to the public. The Fund's investment objective is long-term
capital appreciation through investments primarily in Latin American equity
securities. The Fund has been managed since its inception by CSAM.

    CSAM is a registered investment adviser under the Investment Advisers Act of
1940 with offices located at 466 Lexington Avenue, 16th Floor, New York, New
York 10017 (telephone number (212) 875-3500). CSAM, the institutional asset
management and mutual fund arm of Credit Suisse Group, is a diversified asset
manager, handling equity, fixed income, international and derivative based
accounts in 14 countries.

    13.  ADDITIONAL INFORMATION.  An Issuer Tender Offer Statement on Schedule
TO (the "Schedule TO") including the exhibits thereto, filed with the SEC,
provides certain additional information relating to the Offer, and may be
inspected and copied at the prescribed rates at the SEC's public reference
facilities at 450 Fifth Street, N.W., Room 1024, Washington, D.C. 20549, 233
Broadway, New York, New York 10279 and Citicorp Center, 500 W. Madison Street,
Suite 1400, Chicago, Illinois 60661-2511. Copies of the Schedule TO and the
exhibits may also be obtained by mail at the prescribed rates from the Public
Reference Branch of the SEC at 450 Fifth Street, N.W., Washington, D.C. 20549.

    14.  CERTAIN UNITED STATES FEDERAL INCOME TAX CONSEQUENCES.  The following
discussion is a general summary of the U.S. federal income tax consequences of a
sale of Shares pursuant to the Offer based on current U.S. federal income tax
law, including the Internal Revenue Code of 1986, as amended (the "Code"),
applicable Treasury regulations and Internal Revenue Service rulings. Each
shareholder should consult the his or her own tax advisor for a full
understanding of the tax consequences of such a sale, including potential state,
local and foreign taxation by jurisdictions of which the shareholder is a
citizen, resident or domiciliary.

    U.S. SHAREHOLDERS. It is anticipated that shareholders (other than
tax-exempt persons) who are citizens and/or residents of the U.S., corporations
or partnerships (or certain other entities that are treated as corporations or
partnerships for United States federal income tax purposes) created or organized
in or under the laws of the U.S. or any State thereof or the District of
Columbia, estates the income of which is subject to U.S. federal income taxation
regardless of the source of such income, and

                                       15
<Page>
trusts if a court within the United States is able to exercise primary
supervision over the administration of the trust and one or more U.S. persons
have the authority to control all substantial decisions of the trust ("U.S.
Shareholders"), and who sell Shares pursuant to the Offer will generally
recognize gain or loss for U.S. federal income tax purposes equal to the
difference between the amount of cash they receive pursuant to the Offer and
their adjusted tax basis in the Shares sold. The sale date for tax purposes will
be the date the Fund accepts Shares for purchase. This gain or loss will be
capital gain or loss if the Shares sold are held by the tendering U.S.
Shareholder at the time of sale as capital assets and will be treated as either
long-term or short-term if the Shares have been held at that time for more than
one year or for one year or less, respectively. Any such long- term capital gain
realized by a non-corporate U.S. Shareholder will be taxed at a maximum rate of
20%. This U.S. federal income tax treatment, however, is based on the assumption
that not all shareholders will tender their Shares pursuant to the Offer and
that the continuing ownership interest in the Fund of each tendering shareholder
(including shares constructively owned by such tendering shareholder pursuant to
the provisions of Section 318 of the Code) will be sufficiently reduced to
qualify the sale as a sale rather than a distribution for U.S. federal income
tax purposes. It is therefore possible that the cash received for the Shares
purchased by the Fund would be taxable as a distribution by the Fund, rather
than as a gain from the sale of the Shares. In that event, the cash received by
a U.S. Shareholder will be taxable as a dividend (I.E., as ordinary income) to
the extent of the U.S. Shareholder's allocable share of the Fund's current or
accumulated earnings and profits, with any excess of the cash received over the
portion so taxable as a dividend constituting a non-taxable return of capital to
the extent of the U.S. Shareholder's tax basis in the Shares sold and with any
remaining excess of such cash being treated as either long-term or short-term
capital gain from the sale of the Shares (if the Shares are held as capital
assets) depending on how long they were held by the U.S. Shareholder. If cash
received by a U.S. Shareholder is taxable as a dividend, the shareholder's tax
basis in the purchased Shares will be added to the tax basis of the remaining
Shares held by the shareholder. In addition, if a tender of Shares is treated as
a distribution to a tendering shareholder, a constructive dividend under
Section 305(c) of the Code may result to a non-tendering shareholder whose
proportionate interest in the Fund has been increased by such tender.

    Under the "wash sale" rules under the Code, loss recognized on Shares sold
pursuant to the Offer will ordinarily be disallowed to the extent the U.S.
Shareholder acquires Shares within 30 days before or after the date the tendered
Shares are purchased pursuant to the Offer and, in that event, the basis and
holding period of the Shares acquired will be adjusted to reflect the disallowed
loss.

    The Depositary may be required to withhold 30.5% of the gross proceeds paid
to a U.S. Shareholder or other payee pursuant to the Offer unless either:
(a) the U.S. Shareholder has completed and submitted to the Depositary an IRS
Form W-9 (or Substitute Form W-9), providing the U.S. Shareholder's employer
identification number or social security number, as applicable, and certifying
under penalties of perjury that: (a) such number is correct; (b) either (i) the
U.S. Shareholder is exempt from backup withholding, (ii) the U.S. Shareholder
has not been notified by the Internal Revenue Service that the U.S. Shareholder
is subject to backup withholding as a result of an under-reporting of interest
or dividends, or (iii) the Internal Revenue Service has notified the U.S.
Shareholder that the U.S. Shareholder is no longer subject to backup
withholding; or (c) an exception applies under applicable law. A Substitute Form
W-9 is included as part of the Letter of Transmittal for U.S. Shareholders.

    NON-U.S. SHAREHOLDERS. The U.S. federal income taxation of a Non-U.S.
Shareholder (I.E., any shareholder that is not a U.S. Shareholder as defined
above) on a sale of Shares pursuant to the Offer depends on whether such
transaction is "effectively connected" with a trade or business carried on in
the U.S. by the Non-U.S. Shareholder as well as the tax characterization of the
transaction as either a sale of the Shares or a distribution by the Fund, as
discussed above for U.S. Shareholders. If the sale of Shares pursuant to the
Offer is not so effectively connected and if, as anticipated for most U.S.
Shareholders, it gives rise to taxable gain or loss, any gain realized by a
Non-U.S. Shareholder upon the tender of Shares pursuant to the Offer will not be
subject to U.S. federal income tax or to any U.S.

                                       16
<Page>
witholding tax, provided, however, that such a gain will be subject to U.S.
federal income tax at the rate of 30% (or such lower rate as may be applicable
under a tax treaty) if the Non-U.S. Shareholder is a non-resident alien
individual who is physically present in the United States for more than 182 days
during the taxable year of the sale. If, however, the cash received by a
tendering Non-U.S. Shareholder is treated for U.S. tax purposes as a
distribution by the Fund, the portion of the distribution treated as a dividend
to the Non-U.S. Shareholder would be subject to a U.S. withholding tax at the
rate of 30% (or such lower rate as may be applicable under a tax treaty) if the
dividend does not constitute effectively connected income. If the amount
realized on the tender of Shares by a Non-U.S. Shareholder is effectively
connected income, regardless of whether the tender is characterized as a sale or
as giving rise to a distribution from the Fund for U.S. federal income tax
purposes, the transaction will be treated and taxed in the same manner as if the
Shares involved were tendered by a U.S. Shareholder.

    Non-U.S. Shareholders should provide the Depositary with a completed IRS
Form W- 8BEN or Form W-8ECI in order to avoid 30.5% backup withholding on the
cash they receive from the Fund regardless of how they are taxed with respect to
their tendered Shares. Copies of Form W-8BEN and Form W-8ECI are provided with
the Letter of Transmittal for Non-U.S. Shareholders.

    15.  AMENDMENTS; EXTENSION OF TENDER PERIOD; TERMINATION.  The Fund reserves
the right, at any time during the pendency of the Offer, to amend, extend or
terminate the Offer in any respect. Without limiting the manner in which the
Fund may choose to make a public announcement of such an amendment, extension or
termination, the Fund shall have no obligation to publish, advertise or
otherwise communicate any such public announcement, except as provided by
applicable law (including Rule 14e-1(d) promulgated under the Exchange Act) and
by the requirements of the NYSE (including the listing agreement with respect to
the Shares).

    Except to the extent required by applicable law (including
Rule 13e-4(f)(1) promulgated under the Exchange Act), the Fund will have no
obligation to extend the Offer. In the event that the Fund is obligated to, or
elects to, extend the Offer, the purchase price for each Share purchased
pursuant to the Offer will be equal to 95% of the per Share NAV determined as of
the close of the regular trading session of the NYSE on the Expiration Date as
extended. No Shares will be accepted for payment until on or after the new
Expiration Date.

    16.  MISCELLANEOUS.  The Offer is not being made to, nor will the Fund
accept tenders from, or on behalf of, owners of Shares in any jurisdiction in
which the making of the Offer or its acceptance would not comply with the
securities or "blue sky" laws of that jurisdiction. The Fund is not aware of any
jurisdiction in which the making of the Offer or the acceptance of tenders of,
purchase of, or payment for, Shares in accordance with the Offer would not be in
compliance with the laws of such jurisdiction. The Fund, however, reserves the
right to exclude shareholders in any jurisdiction in which it is asserted that
the Offer cannot lawfully be made or tendered Shares cannot lawfully be
accepted, purchased or paid for. So long as the Fund makes a good-faith effort
to comply with any state law deemed applicable to the Offer, the Fund believes
that the exclusion of holders residing in any such jurisdiction is permitted
under Rule 13e-4(f)(9) promulgated under the Exchange Act. In any jurisdiction
where the securities, blue sky or other laws require the Offer to be made by a
licensed broker or dealer, the Offer shall be deemed to be made on the Fund's
behalf by one or more brokers or dealers licensed under the laws of such
jurisdiction.

THE LATIN AMERICA EQUITY FUND, INC.

October 24, 2001

                                       17